quinazolines has been researched along with Retinal Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, L; Hu, H; Jiang, Q; Li, X; Wang, G; Yan, B; Yao, J; Zhu, Y | 1 |
| Anand-Apte, B; Blobel, CP; Chan, RV; Chiang, MF; Farage, E; Glomski, K; Hewing, NJ; Khokha, R; Swendeman, S; Vermaat, J; Weskamp, G | 1 |
| Schiavo, DM | 1 |
3 other study(ies) available for quinazolines and Retinal Diseases
| Article | Year |
|---|---|
Gefitinib inhibits retina angiogenesis by affecting VEGF signaling pathway.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Cyclin E; Cyclin-Dependent Kinase 2; Disease Models, Animal; Gefitinib; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Oxygen; Platelet Endothelial Cell Adhesion Molecule-1; Quinazolines; Retinal Diseases; Retinal Vessels; Vascular Endothelial Growth Factor A | 2018 |
Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice.
Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; ErbB Receptors; Erlotinib Hydrochloride; Female; Intravitreal Injections; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Oxygen; Protein Kinase Inhibitors; Quinazolines; Retinal Diseases; Signal Transduction; Tissue Inhibitor of Metalloproteinase-3 | 2013 |
Retinopathy from administration of an imidazo quinazoline to beagles.
Topics: Animals; Dog Diseases; Dogs; Female; Imidazoles; Male; Quinazolines; Retina; Retinal Diseases; Time Factors | 1972 |